rs919390

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_152296.5(ATP1A3):​c.*39C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.659 in 1,550,440 control chromosomes in the GnomAD database, including 338,434 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.69 ( 36179 hom., cov: 27)
Exomes 𝑓: 0.66 ( 302255 hom. )

Consequence

ATP1A3
NM_152296.5 3_prime_UTR

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.92

Publications

23 publications found
Variant links:
Genes affected
ATP1A3 (HGNC:801): (ATPase Na+/K+ transporting subunit alpha 3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 3 subunit. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
ATP1A3 Gene-Disease associations (from GenCC):
  • alternating hemiplegia of childhood 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • ATP1A3-associated neurological disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • developmental and epileptic encephalopathy 99
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • dystonia 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • encephalopathy, acute, infection-induced
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 19-41966898-G-C is Benign according to our data. Variant chr19-41966898-G-C is described in ClinVar as Benign. ClinVar VariationId is 329400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.802 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
NM_152296.5
MANE Select
c.*39C>G
3_prime_UTR
Exon 23 of 23NP_689509.1P13637-1
ATP1A3
NM_001256214.2
c.*39C>G
3_prime_UTR
Exon 23 of 23NP_001243143.1P13637-3
ATP1A3
NM_001256213.2
c.*39C>G
3_prime_UTR
Exon 23 of 23NP_001243142.1P13637-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
ENST00000648268.1
MANE Select
c.*39C>G
3_prime_UTR
Exon 23 of 23ENSP00000498113.1P13637-1
ENSG00000285505
ENST00000644613.1
n.3013+351C>G
intron
N/AENSP00000494711.1A0A2R8YEY8
ATP1A3
ENST00000545399.6
TSL:2
c.*39C>G
3_prime_UTR
Exon 23 of 23ENSP00000444688.1P13637-3

Frequencies

GnomAD3 genomes
AF:
0.687
AC:
103955
AN:
151274
Hom.:
36156
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.768
Gnomad AMI
AF:
0.577
Gnomad AMR
AF:
0.646
Gnomad ASJ
AF:
0.551
Gnomad EAS
AF:
0.823
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.711
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.650
Gnomad OTH
AF:
0.660
GnomAD2 exomes
AF:
0.653
AC:
100268
AN:
153474
AF XY:
0.646
show subpopulations
Gnomad AFR exome
AF:
0.773
Gnomad AMR exome
AF:
0.610
Gnomad ASJ exome
AF:
0.556
Gnomad EAS exome
AF:
0.814
Gnomad FIN exome
AF:
0.714
Gnomad NFE exome
AF:
0.650
Gnomad OTH exome
AF:
0.638
GnomAD4 exome
AF:
0.656
AC:
917568
AN:
1399050
Hom.:
302255
Cov.:
64
AF XY:
0.652
AC XY:
450212
AN XY:
690022
show subpopulations
African (AFR)
AF:
0.779
AC:
24617
AN:
31602
American (AMR)
AF:
0.615
AC:
21950
AN:
35720
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
13863
AN:
25182
East Asian (EAS)
AF:
0.815
AC:
29133
AN:
35762
South Asian (SAS)
AF:
0.585
AC:
46357
AN:
79242
European-Finnish (FIN)
AF:
0.716
AC:
35054
AN:
48966
Middle Eastern (MID)
AF:
0.485
AC:
2749
AN:
5666
European-Non Finnish (NFE)
AF:
0.654
AC:
705698
AN:
1078906
Other (OTH)
AF:
0.658
AC:
38147
AN:
58004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
21118
42235
63353
84470
105588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18750
37500
56250
75000
93750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.687
AC:
104018
AN:
151390
Hom.:
36179
Cov.:
27
AF XY:
0.685
AC XY:
50677
AN XY:
73962
show subpopulations
African (AFR)
AF:
0.767
AC:
31545
AN:
41138
American (AMR)
AF:
0.645
AC:
9794
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.551
AC:
1908
AN:
3464
East Asian (EAS)
AF:
0.823
AC:
4220
AN:
5130
South Asian (SAS)
AF:
0.596
AC:
2858
AN:
4794
European-Finnish (FIN)
AF:
0.711
AC:
7458
AN:
10488
Middle Eastern (MID)
AF:
0.531
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
0.650
AC:
44158
AN:
67884
Other (OTH)
AF:
0.663
AC:
1397
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
1556
3112
4669
6225
7781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
802
1604
2406
3208
4010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.627
Hom.:
8087
Bravo
AF:
0.688

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Alternating hemiplegia of childhood 2 (2)
-
-
2
Dystonia 12 (2)
-
-
2
not provided (2)
-
-
1
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.4
DANN
Benign
0.88
PhyloP100
2.9
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs919390; hg19: chr19-42471050; API